Sims Moss Kline & Davis
1000 Abernathy Road, N.E.
Atlanta, Georgia 30328
(770) 481-7200
(770) 481-7210
September 24, 1998
Securities and Exchange Commission
450 5th Street N. W.
Washington, DC. 20549
Re: Bioshield Technologies, Inc.
SEC File No. 333-57767
Form 8-A
Ladies/Gentlemen:
On behalf of Bioshield Technologies, Inc. we transmit herewith a
registration statement on Form 8-A for registration of the Company's securities
under Section 12(b) and Section 12 (g) of the Securities Exchange Act of 1934.
The Company has applied for listing of its Units, Common Stock and Warrants on
the Nasdaq Small Cap Market and in accordance with Form 8-A intends that the
1933 Act registration statement referred to above and the 1934 Act registration
statement filed herewith will become effective concurrently. The Corporation
Finance examiner on this registration statement is Allison Toledo (202)
992-2903.
If there are any questions with respect to this filing please contact the
undersigned.
Very truly yours,
SMK&D
By: Raymond L. Moss
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BIOSHIELD TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
<PAGE>
GEORGIA
------------------------------------------------------
(State of incorporation or organization)
4405 International Boulevard, Suite B-109, Norcross, Georgia
<PAGE>
58-2181628
---------------------------
(I.R.S. employer
identification no.)
30093
-------------------
(Zip Code)
<PAGE>
Securities to be registered pursuant to Section 12(b) of the Act:
<PAGE>
Title of each class
to be so registered
------------------------------------------------------
------------------------------------------------------
------------------------------------------------------
<PAGE>
Name of each exchange on which
each class is to be registered
------------------------------------------------------
------------------------------------------------------
------------------------------------------------------
<PAGE>
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, No Par Value
- ------------ ----------------------------------------------------
(Title of Class)
Redeemable Common Stock Purchase Warrants
----------------------------------------------------------------------------
(Title of Class)
Units
-------------------------------------------------------------------
(Title of Class)
ITEM 1. Description of Registrant's Securities to be Registered.
The information called for by this Item 1 is incorporated
herein by reference from the Registrant's Registration
Statement on Form SB-2 (File No. 333-57767) as filed with the
Commission on June 26, 1998, as amended.
ITEM 2. Exhibits.
1. Articles of Incorporation, as amended, of the Registrant. [3.1] *
<PAGE>
2.ab By-Laws of the Registrant. [3.2] *
3.ab Form of Common Stock Certificate, No Par Value. [4.1] **
4. Form of Unit Certificate [4.2]
5. Form of Warrant Certificate. [4.3] **
6. Form of Public Investor Warrant Agreement [4.6]***
- ----------------------
* Filed as an exhibit to the Registrant's Registration Statement on Form
SB-2 (File No. 333-57767) as filed with the Securities and Exchange Commission
on June 26, 1998. ** Filed as an exhibit to the Registrant's Amendment #1 to the
Registration Statement on Form SB-2 (File No. 333-57767) as filed with the
Securities and Exchange Commission on August 11, 1998.
*** Filed as an exhibit to the Registrant's Amendment #3 to the
Registration Statement on Form SB-2 (File No. 333-57767) as filed with the
Securities and Exchange Commission on September 18, 1998.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereto duly authorized.
BIOSHIELD TECHNOLOGIES, INC.
(Registrant)
Date: September 25, 1998 BY: /s/ Timothy C. Moses
--------------------------
Timothy C. Moses, President
